Stay updated on HQP1351 in GIST and Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the HQP1351 in GIST and Solid Tumors Clinical Trial page.

Latest updates to the HQP1351 in GIST and Solid Tumors Clinical Trial page
- Check4 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.0 to v3.7.1, while the study page continues to display a 403 error.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record. This indicates access to the study details is blocked on the current page.SummaryDifference19%

- Check25 days agoChange DetectedThe UI now includes a 'Find contact information' prompt and the revision label updated to v3.7.0 (replacing the previous v3.6.6).SummaryDifference0.1%

- Check39 days agoChange DetectedThe page now reflects revision v3.6.6, signaling a backend update. No substantive study information or user-facing content appears to be altered.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, reflecting a newer build of the ClinicalTrials.gov page. This update is a maintenance/version bump and does not modify study content, eligibility criteria, or other user-facing information.SummaryDifference0.0%

- Check74 days agoChange DetectedA Publications section was added to the study record, including a PubMed-cited article about Olverembatinib and a note that publications are auto-filled from PubMed; the revision tag updated from v3.6.3 to v3.6.4.SummaryDifference0.3%

Stay in the know with updates to HQP1351 in GIST and Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HQP1351 in GIST and Solid Tumors Clinical Trial page.